Back to 
BANK OF AMERICA CORP /DE/
BANK OF AMERICA CORP /DE/
KNTEShowing 0 of 7 quarters
Position history for BANK OF AMERICA CORP /DE/'s holdings in KINNATE BIOPHARMA INC
As of its Q1 2024 13F, Bank of America held 1,800 shares of KNTE (Kinnate Biopharma), worth $4,788. Bank of America's 13F filings listed KNTE from Q4 2022 to Q1 2024, 6 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., FMR LLC